gene profile assay find high expression susd2 correlate tumor growth experimental colitisassociated colorectal cancer model susd2 mouse generate c57bl6 genetic background delete 15 exon susd2 gene extend data fig 1a b apparent defect growth development include fertility breed body weight behavior data show analysis adaptive innate immune system find alteration number nk1.1 natural killer nk cell cd3cd4 cd3cd8 cell cd19 b cell cd4cd25 cell cd11bf480 macrophage cd11bcd11c conventional dendritic cell dc cd11bly6c monocyte cd11bly6g neutrophil spleen naive susd2 mouse extend data fig 1cj suggest change global immune cell population steady state multiple syngeneic mouse tumor model include allograft mc38 colorectal cancer fig 1a eg7 thymoma fig 1b ovalbuminexpressing b16 b16ova melanoma fig 1c right flank tumor growth significantly blunt susd2 mouse compare wildtype c57bl6 mouse observation indicate loss susd2 inhibit syngeneic tumor growth next ask whether susd2 cd8 cell exhibit alter expression immune checkpoint molecule expression pd1 lag3 ref similar intratumoral wildtype susd2 cd8 cell mouse challenge mc38 eg7 b16ova cell extend data fig 2jl mc38 tumor growth significantly delay susd2 mouse treat pdl1 antibody compare similarly treat wildtype mouse fig 2j translate extend survival fig 2j despite tumor growth show minimal response pdl1 antibody treatment wildtype mouse tumor growth significantly attenuate survival improve pdl1 antibodytreated susd2 mouse challenge either eg7 fig 2k b16f10 fig 2l cell moreover mc38 tumor exhibit significantly delay growth alongside increase survival susd2 mouse compare wildtype mouse treat pd1 antibody fig 2m sum deletion susd2 synergized pd1 pdl1 blockade treatment improve antitumor immunity next examine whether susd2 directly modulate cd8 cell function various immune cell population sort spleen naive c57bl6 mouse cd8 cell highest amount susd2 transcript fig 3a highest amount susd2 mrna protein also detect human cd8 cell isolate peripheral blood mononuclear cell pbmcs fig 3b c stimulation cd3cd28 antibody induce mark increase amount susd2 transcript sort mouse cd8 cell whereas mouse cd4 cell exhibit moderate increase 3 stimulation fig 3d e susd2 mrna protein also augment human cd8 cell stimulation cd3cd28 antibody fig 3f g increase susd2 mrna expression detect cd8 cell cd4 cell infiltrate mc38 tumor compare splenic cd8 cell fig 3h therefore susd2 highly express mouse human cd8 cell expression upregulated cell antigen receptor activation next challenge total splenocytes susd2 oti mouse cognate antigen peptide ovum susd2cd8 oti cell generate significantly higher amount ifn¦Ã gzmb tnf fig 3ik extend data fig 3a well significantly attenuate cell apoptosis assay stain 7aad annexin v antigen stimulation 3 fig 3l compare wildtype cd8 oti cell rnaseq splenic cd8 cell isolate wildtype susd2 oti mouse stimulate ovum 3 extend data fig 3be supplementary table 3 4 detect elevate expression gene encode cell effector molecule include ifng prf1 tnfa gzmc ovaactivated susd2 compare wildtype cd8 oti cell extend data fig 3d e supplementary table 4. susd2cd8 oti cell also exhibit enhance cytotoxicity toward ovum peptidepulsed mc38 eg7 b16ova cell compare wildtype cd8 oti cell fig 3m antigenpresenting assay wildtype susd2 bone marrowderived dendritic cell bmdcs pulse ovum culture cd8 cell isolate wildtype susd2 oti mouse susd2cd8 cell generate significantly higher amount ifn¦Ã regardless bmdc genotype compare wildtype cd8 cell extend data fig 3f suggest inhibitory effect susd2 intrinsic cd8 cell production ifn¦Ã gzmb tnf similar cd4 cell isolate wildtype susd2 otii mouse total splenocytes challenge cognate antigen ovum extend data fig 4a susd2 cell express similar amount foxp3 protein extend data fig 4b comparable capacity block proliferation naive cd4 cell extend data fig 4c compare wildtype cell suggest loss susd2 affect function cd4 cell cell evaluate antitumor function susd2 cd8 cell vivo prim thy1.2 wildtype susd2 oti cell ovum 3 intravenously transfer thy1.1 congenic wildtype mouse challenge eg7 tumor cell 7 cell transfer transfer wildtype oti cell result reduce tumor growth compare mouse inject pb control transfer susd2 oti cell lead complete eradication eg7 tumor growth mouse examine fig 3n suggest superior antitumor response susd2 compare wildtype oti cell transfer susd2 oti cell show higher tumor infiltration elevate production ifn¦Ã gzmb tnf compare wildtype oti cell fig 3o moreover intratumoral susd2 oti cell tcf1pd1 cell phenotype markedly decrease tcf1pd1tim3 cell phenotype compare wildtype oti cell fig 3p q suggest attenuate transition susd2 cell terminal exhaustion collectively result suggest susd2cd8 cell provide superior antitumor effect presumably enhance production cytotoxic factor susd2 contain short 16 amino acid undefined cytoplasmic tail suggest susd2 may initiate intracellular signal directly investigate whether susd2 modulate cd8 cell effector function interaction cell surface protein determine interactome susd2 cd8 cell retrovirally transduce susd2 oti cell v5tagged mouse susd2 empty vector control follow v5 agarose immunoprecipitation liquid chromatography couple tandem m lcmsms susd2 detect precipitate susd2reconstituted susd2 oti cell fig 4a b il2r¦Á highly enrich precipitate susd2reconstituted susd2 oti cell compare susd2 oti cell reconstitute empty vector base number peptide indicate identification confidence number peptidespectrum match psms indicate abundance fig 4a supplementary table 5. susd2 il2r¦Á coimmunoprecipitated susd2reconstituted cell activate ovum 3 fig 4c susd2 pulldown il2r¦Â common ¦Ã chain il15r¦Á fig 4c suggest specific interaction susd2 il2r¦Á authenticity il2r¦Á band verify immunoblotting 293t cell express flagtagged il2ra flagil2ra extend data fig 5a use human il2r¦Á sc365511 flag antibody extend data fig 5b 293t cell cotransfected plasmid express v5susd2 flagil2ra susd2 coimmunoprecipitated il2r¦Á fig 4e f colocalized il2r¦Á cell surface fig 4g overexpressed v5susd2 also pull endogenous il2r¦Á human jurkat cell fig 4h indicate il2r¦Á interact susd2 mouse human cell susd2 il2r¦Á contain sd fig 4b know mediate proteinprotein interaction next test whether interaction susd2 il2r¦Á mediate sd 293t cell coexpressing susd2 mutant protein lack sd susd2 il2r¦Á could detect interaction susd2 il2r¦Á fig 4i deletion sd1 il2r¦Á result loss susd2il2r¦Á interaction deletion sd2 il2r¦Á effect 293t cell coexpressing mutant il2r¦Á protein susd2 fig 4j observation indicate susd2 interact il2r¦Á interaction mediate sd protein il2 signal regulate effector function cd8 cell next investigate whether susd2 interfere il2 signal il2r stimulation naive cd8 cell ¦Ã chain family cytokine il2 il7 il15 induce slight increase expression susd2 contrast strong upregulation susd2 gene transcription cell antigen receptoractivated cd8 cell extend data fig 6a ovaactivated oti cell rest overnight stimulation either il2 il7 il15 ref il2treated susd2 oti cell show enhance phosphorylation stat5 essential transcription factor downstream il2 signal elevate production gzmb compare il2treated wildtype oti cell fig 5a b extend data fig 6b whereas il7 il15treated wildtype susd2 oti cell induce amount pstat5 gzmb fig 5a b extend data fig 6c pstat5 comparable il2treated wildtype susd2 cell extend data fig 6e suggest susd2 specifically affect il2r signal cd8 cell block antibody il2 clone jes61a12 il2r¦Á clone pc61 block antibody il2r¦Â clone tm¦Â1 abolish elevate production ifn¦Ã gzmb susd2 oti cell stimulate suboptimal dose 200 ng ml ovum fig 5c enhance production ifn¦Ã extend data fig 6f increase apoptosis fig 5e susd2 cd8 cell cocultured ovapulsed attenuate block antibody il2 il2r¦Á il2r¦Â cell surface expression il2r¦Á similar wildtype susd2 oti cell fig 5f indicate enhance il2 signal susd2 oti cell due elevate expression il2r¦Á base crystal structure il2 complex il2r¦Á il2 engage il2r¦Á along length sd1 ref test hypothesis susd2 competitively block sddependent bind il2 il2r¦Á perform il2 bind assay use biotinylated il2 293t cell overexpressed v5susd2 andor flagil2ra detect direct bind susd2 biotinylated il2 overexpression v5susd2 significantly decrease bind biotinylated il2 overexpressed flagil2ra fig 5g increase bind biotinylated il2 ovaactivated susd2 oti cell observe compare similarly treat wildtype oti cell fig 5h suggest susd2 negatively regulate il2r signal interfere il2il2r¦Á bind selective target il2il2 antibody immune complex il2 receptor improve il2 immunotherapy tumor examine impact susd2 il2r signal antitumor response vivo compare efficacy il2il2 antibody complex limit growth b16f10 tumor wildtype susd2 mouse use il2r¦Átargeting complex il2ab mouse il2 complexed il2 antibody clone jes61a12 cd122targeting complex il2ab mouse il2 complexed il2 antibody clone s4b61 il2ab minimal effect tumor growth wildtype mouse compare pb injection previously report extend data fig 6g significantly blunt growth b16f10 tumor susd2 mouse extend data fig 6g whereas il2ab cause similar reduction tumor growth wildtype susd2 mouse extend data fig 6h il2abtreated susd2 mouse significantly increase percentage intratumoral cd8 cell produce ifn¦Ã gzmb tnf compare il2abtreated wildtype mouse extend data fig 6ik collectively find indicate inhibitory effect susd2 il2r function next inquire whether interaction susd2 il2r¦Á require inhibitory effect susd2 cd8 cell activation ovaactivated susd2 oti cell retrovirally transduce green fluorescent protein gfptagged fulllength susd2 susd2gfp susd2gfp empty vector evgfp 50 transduction efficiency fig 6a observe decrease production ifn¦Ã gzmb fig 6b c increase apoptosis fig 6d gfp oti cell reconstitute susd2gfp susd2gfp compare cell reconstitute evgfp moreover transduction susd2 oti cell susd2gfp susd2gfp inhibit bind biotinylated il2 susd2 oti cell fig 6e il2induced stat5 phosphorylation fig 6f result suggest loss susd2 interaction il2r¦Á ablate inhibitory effect cd8 cell effector function vitro determine whether susd2il2r¦Á interaction modulate antitumor effector function cd8 cell vivo adoptively transfer thy1.2susd2 oti cell transduce susd2gfp susd2gfp evgfp thy1.1 mouse challenge eg7 tumor cell 7 cell transfer susd2gfp susd2 oti cell exhibit impair capacity control eg7 tumor growth susd2gfp susd2 oti cell control tumor growth level comparable evgfp susd2 oti cell fig 6g susd2gfp susd2gfp susd2 oti cell attenuate tumor infiltration decrease production ifn¦Ã gzmb tnf fig 6h significantly decrease 42 cd8 cell fig 6i increase 77 cd8 cell fig 6j compare evgfp susd2 oti cell indicate susd2il2r¦Á interaction require inhibitory role susd2 antitumor effector function cd8 cell extend data fig 8. evaluate potential susd2 immunotherapy target cancer investigate role regulate antitumor efficacy human cd19 hcd19targeting chimeric antigen receptor car cell mouse el4 thymoma cell line engineer express hcd19 extend data fig 7a wildtype susd2cd8 cell retrovirally transduce secondgeneration car contain portion hcd19 single chain variable fragment scfv fuse signal domain mouse cd28 mouse cd3¦Æ sequence first third itams immunoreceptor tyrosinebased activation motif inactivate sort car cell 98 live cell purity transfer rag2 mouse inoculate el4hcd19 tumor cell 7 car cell transfer extend data fig 7b wildtype car cell restrain tumor growth day 13 tumor cell inoculation tumor growth rebound day 13 lead similar survival rag2 mouse without wildtype car cell transfer fig 7a transfer susd2 car cell significantly reduce tumor growth day 16 tumor cell inoculation translate improve survival compare wildtype car cell fig 7a detect enhance production ifn¦Ã gzmb tnf well improve cell survival intratumoral susd2 car cell compare wildtype car cell fig 7b c intratumoral susd2 wildtype car cell similar expression pd1 lag3 fig 7d e deletion susd2 car cell lead improve antitumor response el4hcd19 tumor model next deplete endogenous susd2 wildtype car cell use cas9 nucleoprotein rnp complex electroporation extend data fig 7c transfer susd2depleted car cell rag2 mouse result improve control el4hcd19 tumor increase survival compare transfer wildtype car cell fig 7f observe increase production ifn¦Ã gzmb tnf il2 fig 7g increase percentage tcf1pd1cd8 cell decrease percentage tcf1pd1tim3 cd8 susd2depleted car cell compare wildtype car cell fig 7h suggest therapeutic deletion susd2 improve effector function car cell counteract differentiation terminally exhaust car